Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1508 ARTÍCULOS , VIENDO DEL 181 AL 195

A possible significant role of zinc and GPR39 zinc sensing receptor in Alzheimer disease and epilepsy

Khan MZ.

Biomed Pharmacother. 2016 Apr;79:263-72. doi: 10.1016/j.biopha.2016.02.026. Epub 2016 Mar 11.

Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics

Sala Frigerio C, De Strooper B.

Annu Rev Neurosci. 2016 Jul 8;39:57-79. doi: 10.1146/annurev-neuro-070815-014015. Epub 2016 Apr 4.

[Alzheimer patients: another approach]

Marrocco J, Hudon J.

Krankenpfl Soins Infirm. 2016;109(3):74-5, 90-1.

Are cognitive interventions effective in Alzheimer's disease? A controlled meta-analysis of the effects of bias

Oltra-Cucarella J, Pérez-Elvira R, Espert R, Sohn McCormick A.

Neuropsychology. 2016 Jul;30(5):631-52. doi: 10.1037/neu0000283. Epub 2016 Apr 7.

The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease

Lan YL, Zou S, Chen JJ, Zhao J, Li S.

Neural Plast. 2016;2016:4626593. doi: 10.1155/2016/4626593. Epub 2016 Jan 6.

Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models

Kimura N.

Int J Mol Sci. 2016 Apr 5;17(4):503. doi: 10.3390/ijms17040503.

Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy

Nabavi SF, Braidy N, Orhan IE, Badiee A, Daglia M, Nabavi SM.

Phytother Res. 2016 Apr;30(4):532-9. doi: 10.1002/ptr.5569. Epub 2016 Jan 11.

Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease

Jayne T, Newman M, Verdile G, Sutherland G, Münch G, Musgrave I, Moussavi Nik SH, Lardelli M.

J Alzheimers Dis. 2016 Apr 4;52(3):781-99. doi: 10.3233/JAD-151186.

Granulovacuolar degeneration: a neurodegenerative change that accompanies tau pathology

Köhler C.

Acta Neuropathol. 2016 Sep;132(3):339-59. doi: 10.1007/s00401-016-1562-0. Epub 2016 Apr 9.

AChE and the amyloid precursor protein (APP) - Cross-talk in Alzheimer's disease

Nalivaeva NN, Turner AJ.

Chem Biol Interact. 2016 Nov 25;259(Pt B):301-306. doi: 10.1016/j.cbi.2016.04.009. Epub 2016 Apr 7.

sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A.

Int J Biochem Cell Biol. 2016 Jun;75:104-11. doi: 10.1016/j.biocel.2016.04.002. Epub 2016 Apr 7.

Influence of APOE Genotype on Hippocampal Atrophy over Time - An N=1925 Surface-Based ADNI Study

Li B, Shi J, Gutman BA, Baxter LC, Thompson PM, Caselli RJ, Wang Y; Alzheimer’s Disease Neuroimaging Initiative.

PLoS One. 2016 Apr 11;11(4):e0152901. doi: 10.1371/journal.pone.0152901. eCollection 2016.

The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders

French SW, Mendoza AS, Peng Y.

Exp Mol Pathol. 2016 Jun;100(3):426-33. doi: 10.1016/j.yexmp.2016.03.010. Epub 2016 Apr 9.

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease

Prati F, Cavalli A, Bolognesi ML.

Molecules. 2016 Apr 8;21(4):466. doi: 10.3390/molecules21040466.

DYRK1A inhibition as potential treatment for Alzheimer's disease

Stotani S, Giordanetto F, Medda F.

Future Med Chem. 2016 Apr;8(6):681-96. doi: 10.4155/fmc-2016-0013. Epub 2016 Apr 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias